Published
For example, both brands have the same strength 10 mg.
Should Oxycodone Sandoz Controlled release tablets 10 mg be documented on the same page as OxyContin Reformulated Modified release tablets 10 mg in the ward register?
Or should Oxycodone Sandoz Controlled release tablets 10 mg be documented on a difference page ? In other words, Oxycodone Sandoz Controlled release tablets 10 mg to be documented on one page, and OxyContin Reformulated Modified release tablets 10 mg to be documented on another different page.
Hopefully someone will come along who knows about your exact situation, but my best guess in the meantime would be that it if you're completely on paper, there probably should be some indication whether the patient received the generic or brand. Seems like this would be prudent to cover bases should there be a problem with one of the lots or the patient has some kind of reaction or something (?)
Probably easiest to keep track on separate sheets.
Oxycodone and oxycontin are not the same. The first is immediate release and short acting ( 3 - 6 hr.) and may be prescribed prn or scheduled. The second is an extended release version (8 - 12 hours) and should not be prescribed prn. Confusing the two could lead either to overdose or severely undertreated pain. No bueno.
Therefore, i would expect to document on a different page.
John 2018
24 Posts
Can anybody help the following question?
In Australia, Oxycondone controlled release has two different brands:
Oxycodone Sandoz Controlled release tablets, 5 mg, 10 mg, 20 mg, 40 mg, 80 mg.
OxyContin Reformulated Modified release tablets, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 80 mg.
Above two brands contain the same medication Oxycondone controlled release , but with difference strengths.
In the ward register, should a different brand use a different page? or should these two brands be mixed together as the same medication Oxycontin on the same page in the ward register?
Please advise.
Thanks.